ViewRay, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRAYQ research report →
About the company
ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control.
- CEO
- Scott Drake
- IPO
- 2015
- Employees
- 295
- HQ
- Oakwood Village, OH, US
Price Chart
- Market Cap
- $18.34K
- P/E
- -0.04
- P/S
- 0.04
- P/B
- 0.05
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
- Gross Margin
- 9.83%
- Op Margin
- -104.81%
- Net Margin
- -105.21%
- ROE
- -85.33%
- ROIC
- -60.29%
- Revenue
- $102.21M · 45.76%
- Net Income
- $-107,330,000 · 2.47%
- EPS
- $-0.59 · 11.94%
- Op Income
- $-107,127,000
- FCF YoY
- -50.21%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -21.16
- Avg Volume
- 60.76K
Get TickerSpark's AI analysis on VRAYQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VRAYQ coverage
Recent articles, reports, and earnings notes.
No research on VRAYQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRAYQ report →Similar companies
Peers in the same neighborhood.